Demand Is Up, Supply Is Down: What the Acupuncturist Shortage Means for Multi-Practitioner Clinics

By Luke Bujarski  ·  July 2026  ·  6 min read

The demand story in acupuncture is easy to feel. More people are looking for care than at almost any point in the last decade. The country is backing away from opioids and hunting for something else for pain. Insurers are slowly coming around. People are booking for stress, for sleep, for fertility, for all the things they used to tough out on their own. The studies disagree on the size of the wave. They agree on the direction. It is rising.

The supply of acupuncturists is moving the opposite way. Ten schools have closed in five years, including some of the oldest and most respected in the country. Enrollment is falling, tuition runs high, new-graduate income runs low, and a federal rule expected in 2028 is likely to strip financial aid from many of the programs still open. Fewer schools, fewer graduates, fewer new practitioners entering the field.

For a founder running a multi-practitioner practice, those two trends land somewhere specific, and the landing is not entirely comfortable. A good acupuncturist has never been more valuable or harder to replace. A good acupuncturist has also never had an easier time walking out to build something of their own.

That second part is the shift most founders have not fully priced in. A decade ago, striking out alone meant learning to market from scratch, and most practitioners were bad at it. Today a practitioner with a loyal following, a phone, and a handful of inexpensive tools can fill a schedule faster than ever. Booking, reminders, reviews, local search, a clean website built in an afternoon. The barrier that used to keep good associates in place has quietly fallen. For an established practitioner with a book already built inside someone else's clinic, the hardest part of going solo is close to solved before they even give notice.

So the sharpest competition a multi-practitioner founder faces may be working in the exam room down the hall.

The job of running the practice has changed accordingly. Holding onto a good practitioner now comes down to two things, and both are economic before they are emotional. Keep them busy, and keep them happy.

Busy is the one founders tend to underrate. A practitioner staring at gaps in the schedule starts doing math. Slow weeks read as a signal that the practice is not working, and a restless practitioner with a loyal book and easy marketing tools is a flight risk. A full, predictable schedule is the strongest retention tool a founder has. It gets built on purpose, through systems that generate revenue predictably.

Happy grows out of busy, and out of one more thing: the sense that the practice is somewhere worth building a career. That the founder knows the numbers, runs the business with intention, and is steering toward something specific. Practitioners can feel the difference between a clinic that is drifting and one that is being run. The drifting clinic loses its best people first, because its best people have the most options.

Underneath both is retention. A practice that keeps its patients keeps its practitioners busy, almost as a byproduct. When I built an economic model of my own clinic, Chrystal, one number reframed everything for me. Nearly half of the year's revenue came from patients who had been with us for the long haul, the regulars who kept coming back on their own. A relatively small, loyal core was carrying the practice. That core is what fills schedules week after week with no marketing spend behind it. Let it erode, and every practitioner in the building feels the gaps first.

Multi-practitioner clinics carry a sharper version of this risk that solo practices never face. When a clinic's most loyal patients are tied almost entirely to one practitioner, that practitioner is holding a real share of the practice's revenue inside relationships that feel, to the patient, personal. If that practitioner leaves, and leaving has never been easier, those relationships tend to go along. Years of built-up loyalty walk out the door attached to one person, and the practice cannot rebuild it quickly.

None of this is a reason for a founder to feel cornered. The same forces that make good practitioners mobile make an established, well-run practice more valuable than it has ever been. Demand is rising, capable operators are scarce, and no outside capital is flooding in to build polished competitors, because the economics of cash-pay acupuncture keep that kind of money at a distance. The founders who read this decade as an opening, and who build the systems to hold onto their patients and their people, are positioned to win at a scale that was not on the table before.

That takes a particular discipline: knowing the real numbers, building revenue that shows up predictably, and treating the business side of the practice with the same seriousness a good acupuncturist brings to a treatment plan. The discipline is learnable, and there has never been a better decade to build it, with the wind at the back of every established clinic.

An essay can only go so far. It can argue that the game has shifted from filling the schedule to keeping the people who fill it, patients and practitioners alike. It cannot tell a particular founder where their own practice is exposed, how concentrated the revenue really is, or what a single departure would actually cost. That answer lives in the clinic's own numbers, and most founders are surprised by what those numbers say once they sit down and look honestly.

A founder goes into practice ownership to build something of their own. In a decade when the best practitioners can build something of their own just as easily, the practices that last will be the ones run well enough to be worth staying in. The demand is coming regardless. The open question is who gets to keep it.

The Real Cost of AI for Clinics: Knowing What to Build, and How

For a long time, software was something you bought.

You picked a platform, paid the monthly fee, and bent your clinic to fit whatever the vendor decided you needed. Half the features you never touched. The one report you actually wanted didn't exist. That was the deal, and everyone took it, because building your own meant hiring engineers and spending six figures you didn't have.

AI changed that, though not in the way the hype says. It's worth being precise about what actually changed and what didn't.

Start with what didn't. You are not going to replace your practice management system, the Jane or Cliniko or IntakeQ you run the clinic on. Good luck standing up a booking and records platform that stays online, processes payments, survives an audit, and protects patient data, then keeping it that way at two in the morning when it goes down. That is not the opportunity. Anyone selling you a rebuild of your core platform is selling you risk you were smart to offload in the first place. Your practice management system is the commodity layer. Records, scheduling, payments, storage, security, uptime. You rent that forever, and you should.

What changed is everything that sits on top of it.

Your platform becomes the system of record, the clean source of truth. The clinic-specific layer gets built on top, the view of your business no vendor will ever ship because it exists only inside your clinic. Traditional SaaS can't follow you up there. Its whole business is selling one product to ten thousand clinics. Customized at scale is the thing it structurally cannot do.

Here's where founders get the math wrong. AI made the code cheap. It did not make the software cheap.

Custom doesn't replace your practice management subscription. It sits on top of it. You keep paying for the system you run on, and you invest in the layer above it, so this is an addition to the budget, and additions have to earn their place. The upfront number is real. Maintenance after that runs lower, but lower is not zero, and it arrives in lumps: when the export format changes, when your needs move, when something drifts. The honest shape is a trade. A predictable monthly fee forever, in exchange for money upfront and smaller costs here and there. Which is exactly why saving money is the wrong reason to do any of this. Do it for ROI. When I built an economic model for my own clinic, it surfaced about $43,000 in recoverable revenue at zero incremental cost. That's the frame every tool gets held to now: what did it return.

Now the part the hype skips.

When building software was expensive, the barrier was code. You needed people who could write it. AI didn't remove that barrier so much as lift it up and show you the two sitting underneath. The first is knowing what your clinic actually needs, the right question to build against. The second is knowing how to build it without hurting yourself.

Take a simple patient follow-up tool. AI will write it, and it will work on your laptop. What AI will not do is stop and tell you where the patient data goes while that tool runs. Send identifiable data off to a server without the right setup and you've created an exposure you didn't know existed. The decision to keep the whole thing running locally, so patient data never leaves the machine, is what keeps you safe, and AI won't make that call unless you already knew to ask for it. Same with configuring the data properly. Same with knowing what your export does and doesn't contain. AI collapsed the typing. It exposed the expertise that was always underneath the typing.

That's the thing founders find out the hard way. "Just build it" turns out to be a stack of decisions you didn't know were there. The learning curve doesn't announce itself until you're standing in the middle of it.

UX is the same story. Paying attention to the person using the tool is only the entry fee. The skill is designing a flow a slammed front desk will actually adopt, then reworking it three or four times until they do, because they won't the first time. That's product development, and it's a craft with reps behind it. The failure mode here is quiet. A tool that works fine and nobody opens. That one is worse, because you paid for it and got nothing back.

None of this makes it an enterprise game. Deployed right, it runs the other way. For the first time, a small clinic can run software as sharp and as tailored as a big one's. The tools that used to belong to whoever could afford a dev team now belong to whoever is willing to make the investment. For the independent operator, this is the most level the playing field has ever been.

So should you build it yourself? Sometimes, genuinely, yes. If it's low stakes, touches no patient data, and costs you nothing when it's clunky, a quick internal calculator, a one-time look at a number, build it and learn something. The calculus flips the moment the tool is load-bearing, or it touches PHI, or other people have to adopt it. That's where the invisible work lives. That's where doing it yourself stops being thrift and starts getting expensive.

Which is the real case for a partner. Your time is part of it. Every hour spent wiring this together is an hour you're not treating patients or leading your team, and the hallmark of a good founder is delegation, knowing what to hand off. The deeper reason is that the work left over is skilled work that looks smaller than it is, and a few of the ways it bites you cost real money to learn firsthand. What you want is someone who knows your vertical cold, who understands a clinic and not just code, who jives with your team, cares about your mission, and is genuinely good to work with.

All of it takes a mindshift. Software stops being a monthly bill you tolerate, or tech bought for tech's sake, and becomes an investment you make on purpose, judged on what it returns. The clinics that make that shift run more responsive, more profitable operations, and the gap compounds year over year. AI made that possible for the first time. Building it well is still the work. Eventually that's what separates the winners, not who had access to AI, because everyone will, but who knew what to build with it, and had the sense to build it right.

Written by Luke Bujarski. Founder, LUFT

How Insurance Builds Loyalty in Acupuncture Practices

By Luke Bujarski  ·  June 2026  ·  7 min read

There is an assumption almost every acupuncture founder with an insurance-mix practice carries. Self-pay patients are the committed ones. The believers. Insurance patients are transactional. They come when it's covered and leave when it isn't.

The data says otherwise, and the gap is not small.

In a multi-practitioner acupuncture practice we analyzed recently, insurance patients were nearly three times more likely to still be active than their cash-pay counterparts, among patients who had crossed the six-visit threshold. When we looked at who lapsed, insurance patients averaged four more visits before stopping. And on the retention metric that matters most, the share of patients who establish a durable long-term relationship with the clinic, insurance patients were running at nearly three times the rate of self-pay patients paying full price.

The per-visit reimbursement was lower on the insurance side, as it usually is. But the relationship lasted longer, ran deeper, and generated more total value per patient.

The founder we showed this to was surprised. She had assumed the opposite.

The reason is not complicated once you see it, but it requires thinking about how acupuncture actually works on a patient rather than how it shows up in a booking report.

Acupuncture is cumulative. The first session might produce relaxation, maybe some mild soreness. The second and third visits are where something starts to shift, but the shift is subtle enough that most patients can not be certain they didn't just sleep better that week. The moment of genuine understanding, when a patient knows from their own body that this medicine works for them, usually doesn't arrive until somewhere in the middle of a real treatment arc.

Before that moment, the patient is operating on faith. And faith is expensive to sustain when every visit costs full price.

Insurance lowers the cost of continuing below the threshold where uncertainty resolves against coming back. The copay is manageable. The card is in the wallet. So the patient returns for visit three and visit four, not because they're convinced yet, but because the friction of continuing is low enough that they don't have to decide whether they believe in it. And somewhere in that stretch, the penny drops. They feel it. The insurance was the bridge they didn't know they needed to cross.

The self-pay patient at full rate faces a different arithmetic. Every visit is a deliberate decision to spend real money on something whose value they can't yet verify. A meaningful share of those patients stop before the penny drops. Not because the medicine failed. Because the economics of uncertainty resolved against continued commitment before the medicine had enough visits to prove itself.

There is also a billing dimension to this that most founders undercount.

Insurance requires periodic re-evaluation of patient progress, typically every thirty days or every sixth visit. Those re-evaluations are billed separately from the standard treatment visit and reimbursed at their own rate. A patient who stays through a full treatment arc triggers two or three of those re-evaluation billings across the relationship. The cash-pay patient on the same arc generates none.

Which means the per-visit revenue gap between insurance and self-pay is narrower in practice than it looks in the raw numbers, and possibly closes considerably when you account for the full billing picture across a treatment relationship. The conventional wisdom that insurance patients are both less profitable and less loyal turns out to be wrong on both counts.

The founder who believes her self-pay patients are her most loyal is usually right about the ones she can see. What she is not seeing is all the self-pay patients who didn't make it to the penny-drop and left quietly. They are in the data. They just look like every other early dropout.

Meanwhile, the insurance patient who lapsed after fourteen visits is a categorically different situation. That patient almost certainly crossed the threshold. They understand the medicine. They are not leaving because acupuncture didn't work. They are leaving for a reason that is probably addressable, if you know what it is.

Those two patients need completely different responses from your practice. In a standard retention report, they look identical.

The harder question is whether you can see the difference in your own data. Not as an argument, which this post has made, but as a list of specific patients, at specific points in their journeys, sorted by what they actually need from you right now.

That is the work this post cannot do.

About the author

Luke Bujarski

Luke Bujarski is the founder of LUFT, a strategic consulting practice for independent health clinics.

Second-Order Effects

The numbers you can model are only part of the story.

At Chrystal Clinic, when we built the economic model, we found $42,927 in year-one recoverable revenue. We broke it into five initiatives. We knew the dollar amount attached to each one. The acupuncture repricing was $32,113. The MVP recruitment sprint was $6,978. The retention automations were $3,491. Everything had a number, and the numbers were auditable.

What we did not model was what happens next.

We pushed more patients through their treatment arcs. We re-engaged patients who had been drifting toward lapse. We identified the top revenue generators and started treating them differently. These were the measurable interventions. They had clear inputs and clear outputs and we could track them over time.

But a patient who completes a treatment arc is a different kind of patient afterward. She is more confident in the modality. She has experienced what the treatment was actually designed to do. She refers. She comes back with a new complaint rather than going somewhere else. She becomes, in the language of the model, part of the 6+ cohort, where patients were worth 8.7 times more over their lifetime than someone who visited once.

We had not modeled any of that. We didn't try to. The honest answer is that we weren't sure what to model.

In a different clinic, we recently looked at MVP visit drift as a primary constraint. Active MVPs had reduced their visit frequency materially over four years. The direct calculation was significant, roughly $24,000 per year in lost revenue from patients spacing out rather than lapsing entirely. That number is real and at least partially recoverable through a focused scripting interventions.

But the number in the model is not the only number that changes when you fix the drift.

A patient whose visit frequency is restored is a patient whose treatment is working. That's not a clinical observation, it's an economic one. Patients who are experiencing clinical value return. Patients who are not, drift. When you close the drift, you are not just recovering the revenue from the missing visits. You are extending the lifetime of the relationship. You are resetting the referral probability upward. You are increasing the likelihood that this patient becomes the person who sends two or three others to you over the next decade.

The model did not capture any of that. It captured the direct recovery. The true number, when second-order effects compound, is likely somewhere between 1.5 and 2 times the direct calculation. We say that honestly in our work, and we say it because we have watched it play out.

There is a version of this problem that is easy to name. If you retain a patient who would have lapsed, you get the revenue from the visits she would have missed. That's the first-order effect, and it's the one the model can hold cleanly.

The harder version is the downstream shape of a healthier patient base. A clinic with a stronger retention profile has more referrals because its patients are getting outcomes. It has lower acquisition pressure because more of its growth comes from within. It has a more stable revenue base because it is less dependent on constant new patient flow. These things compound. They are not captured in a one-year calculation.

The embarrassing part, in retrospect, is that when we were running Chrystal on instinct, we weren't thinking about any of this. We were thinking about next week's schedule. The new patient coming in on Tuesday. Whether the slow season would be slow again this year. The economic picture we built later revealed not just what was leaking, but what the shape of the whole thing could have been if we had acted on the signals earlier.

The second-order effects had been accumulating the whole time. We just hadn't been counting them.

The reason this matters for most founders is that the decision economics look different once you account for it.

A retention intervention that costs $8,000 and recovers $14,000 in direct revenue looks like a modest return. That same intervention, when it extends MVP lifetimes, increases referral rates, and shifts the clinic's Acquisition Dependency Index over two years, looks like one of the highest-leverage decisions the business made. The first number is easy to model. The second number requires a different kind of accounting.

What we can say with confidence is that the model almost always understates the value of the intervention. The direct calculation is the floor. The clinics that understand this tend to act on retention findings with more urgency than the direct number warrants, because they know the direct number is incomplete.

The ones that focus only on the floor are still right to act. They're just not fully seeing what they're building.

Finding the measurable leaks in a specific clinic requires looking at that clinic's specific data. The second-order story is real, but it starts with the first-order number, because that's the evidence that the constraint exists and the intervention is worth the cost.

If you don't yet know your visit-1 to visit-2 number, or where your MVP cohort is drifting, those are the questions the model answers first. The compounding comes after.

About the author

Luke Bujarski

Luke Bujarski is the founder of LUFT, a strategic consulting practice for independent health clinics.

The Exit Mindset

By Luke Bujarski  ·  April 2026  ·  6 min read

Before I co-founded Chrystal Clinic, I spent fifteen years building global travel and hospitality brands. One pattern repeated itself across every market I worked in. The operators who sold at premium multiples were rarely the ones who had spent the final year before their sale preparing to exit. They were the ones who had been running with a specific kind of discipline for years before any buyer appeared.

In vacation rentals specifically, data-driven operators consistently outperformed their peers on revenue before they outperformed on exit price. They tracked occupancy curves, revenue per available night, guest retention rates, seasonal demand patterns, and channel mix. That discipline made them better operators in every quarter they ran the business. When a buyer eventually appeared, the premium multiple was a consequence of how they had been operating, not a separate project they undertook in anticipation of a sale.

I think about that pattern constantly now that I work with cash-pay clinic founders. The consolidation wave that reshaped hospitality is arriving in medspas and integrative health practices. The founders who understand what that means early enough to build accordingly are in a fundamentally different position than the ones who don't. But more importantly, the discipline that positions a clinic for a premium exit is the same discipline that makes it more profitable to operate right now. You don't have to be selling to benefit from building like you are.

What the discipline actually looks like

Operating with an exit mindset doesn't mean hiring a sell-side advisor or getting a valuation. It means building economic visibility into how you run the business at the level that makes it provable to someone who doesn't already know it.

In practice that means four things. Economic visibility at the patient level: not just total revenue, but where it comes from, how stable it is, and how concentrated it is in patients or providers who could leave. Retention tracking with real numbers: not a feel for who the regulars are, but the actual visit-two conversion rate, the arc completion rate, the size and trajectory of the loyal patient cohort. Service economics by provider hour: not which services are popular, but which are genuinely profitable at the time commitment required to deliver them. And capacity clarity: a number that describes how close the business is to its real operational ceiling and what the path to the next revenue level actually requires.

None of these are exit preparation tasks. They are operating fundamentals that most clinic founders don't have. And their absence costs money every month, long before any buyer is ever in the room.

What we found at Chrystal Clinic

When we built the economic model for Chrystal Clinic, we weren't thinking about a sale. We were trying to understand why growth felt harder than it should. What came back from five years of appointment-level data was a picture of the business we had never been able to see before: which patients were driving the economics, where revenue was leaking, which services were carrying their weight and which weren't, how close we were to the real capacity ceiling.

The model identified $42,927 in year-one incremental revenue at zero additional cost. Every dollar of it came from the patient base we already had. The discipline of building that visibility changed how we made decisions across every time horizon. In the near term we stopped doing things the data said weren't working. In the medium term we concentrated on three specific levers the model identified. Looking further out we had a capacity ceiling number and a clear picture of what reaching the next revenue level required.

That is also, not coincidentally, exactly what a sophisticated buyer wants to see.

What buyers look for

Private equity has been consolidating medspas and integrative health practices for several years now. When a PE firm evaluates a clinic acquisition, they are running a version of the same analysis a hospitality buyer runs on a vacation rental portfolio. Revenue predictability. Concentration risk. Retention stability. Margin defensibility at scale. The questions are the same. What differs is whether the founder can answer them with data or with estimates.

A founder who has been running on a live economic model for two or three years walks into that conversation with documentation a buyer can trust. The visit-two conversion rate isn't a guess. The provider revenue concentration is quantified. The retention trend is visible over time. The service economics are separated by hour, not just by total revenue. That founder is presenting evidence. The one who hasn't built the model is presenting estimates dressed as evidence. Sophisticated buyers know the difference and it moves the price.

The compounding argument

The model that makes a business sellable takes time to build and time to validate. A founder who starts building it now has something a founder who starts six months before a potential sale never will: a documented operating history at the economic level. That history is evidence, not projection. It is the difference between telling a buyer what the business is worth and showing them.

But the more important point is what happens before any buyer is ever in the room. The founder running with this discipline is making better decisions every quarter. She is not adding services that compress margin without realizing it. She is not missing the retention leak at visit two because she has no way to see it. She is not discovering that the majority of her revenue runs through one provider at the point when it is too late to fix it. The model doesn't wait for the exit to pay off.

The parallel brought full circle

In hospitality, the gap between a good asset and a premium exit was almost never the asset itself. It was the ability to prove what you had. The operators who built with that discipline didn't do it because they were planning to sell. They did it because it was a better way to run the business. The exit, when it came, reflected everything they had built.

Cash-pay clinics are earlier in that curve. The consolidation is underway but the majority of founders haven't begun building the economic infrastructure that will determine where they sit when it reaches them. The ones who start now have time. The ones who wait until a buyer is at the table are already negotiating from a weaker position than they need to be.

You don't have to be selling to benefit from building like you are. That is the whole argument.

Luke Bujarski is the founder of LUFT and co-founder of Chrystal Clinic. LUFT builds economic models for cash-pay health clinics. luft.net

About the author

Luke Bujarski

Luke Bujarski is the founder of LUFT, a strategic consulting practice for independent health clinics.

What AI Actually Did For Our Clinic

By Luke Bujarski  ·  April 2026  ·  6 min read

For the first several years of running Chrystal Clinic, I made decisions the way most clinic founders make them. Pattern recognition, gut feel, and a general sense of whether things were moving in the right direction. We tracked revenue. We knew roughly which services were busy. We had a feel for which patients were regulars. What we didn't have was a structured picture of the economics underneath any of it.

That meant every significant decision — whether to add a service, change our pricing, invest in a new marketing channel, think about adding a provider — was made without knowing what it was actually worth or what it would cost at the economic level. We were operating, but we weren't operating with a model. There's a difference, and I didn't fully understand how large that difference was until we built one.

How AI entered the process

We started with five years of appointment-level data from Jane.app. The goal was to build an economic model of the clinic from the ground up — not a dashboard, not a revenue report, but a structured analytical framework that traced every patient through their full lifecycle with us and quantified what we were actually seeing in the business.

AI was part of the process from early on, both in the analysis itself and in the strategic planning conversations that followed. We used it to process patient cohorts at a scale that wouldn't have been possible manually, to surface patterns in retention behavior across five years of appointment records, and to build scenario models that could answer specific questions about what different strategic moves were actually worth.

The process was genuinely iterative. Early outputs looked rigorous and answered things that turned out not to matter much. The analysis got sharper as the questions got sharper. That iteration — figuring out which questions were actually worth asking for a clinic structured the way Chrystal was, in the market we were in — was where most of the real work happened.

The part nobody talks about

Most of what gets written about AI in business contexts skips the part where the work is actually hard. The reality of building something like this from clinic data is considerably less frictionless than the tools tend to suggest.

Data cleaning alone took significant time. Jane exports are not analysis-ready. Five years of appointment records contain gaps, duplicates, inconsistent service categorization, and practitioner attribution irregularities that accumulate quietly over time. Before any AI tool could do meaningful work, the data had to be normalized — a process that required understanding both what the export structure looked like and what the clinical reality it was supposed to represent actually was.

Then there were the assumptions. Every formula in the model rests on a judgment call. What counts as a retained patient. What the relevant time window is for flagging a patient approaching likely drop-off. How to attribute revenue when a single visit touches multiple services. How to define the loyal patient cohort in a way that's meaningful rather than arbitrary. Each of those assumptions had to be validated against operational reality — cross-checked against what we actually knew about the clinic — rather than just accepted because the math produced a clean output.

Then the tools themselves. Different analytical tasks required different approaches and different AI-assisted workflows. Pattern recognition across the full patient dataset looked different from scenario modeling for a specific strategic question, which looked different again from building cohort analyses that needed to update automatically as new data came in. Knowing which tool to use for which portion of the work, and how to structure the prompts and inputs to get outputs that were actually interpretable, was a skill built through iteration rather than something that came with a subscription.

The learning curve was real and it was steep. Anyone telling you otherwise is selling something.

What AI could and couldn't do

Once the data was clean and the model structure was defined, AI was genuinely powerful. It could hold five years of appointment records in view simultaneously while asking questions that would have taken weeks to answer manually. It surfaced patterns in patient behavior — specifically around retention — that weren't visible in any report we had been looking at. It built the retention funnel, the cohort tables, the service economics breakdowns, and the MVP analysis in a fraction of the time a human analyst would have needed.

What it could not do was tell us which metrics actually mattered for a clinic structured the way Chrystal was. A 49% visit-one-to-visit-two drop-off rate came back as a number. Whether that number represented a crisis or something roughly normal for an integrative wellness practice in our market required someone who understood clinic economics to interpret it. The same was true for every significant finding. The AI produced the output. The judgment about what the output meant, and whether it pointed to a real constraint or a false signal, had to come from somewhere else.

That judgment doesn't come from the tools. It comes from having thought carefully about how cash-pay clinic economics actually work, having defined the right questions before the analysis begins, and having enough operational context to know when a finding is meaningful and when it's an artifact of how the data was structured.

What changed

The model changed how we operated at every time horizon.

In the near term, we stopped doing things the data said weren't moving anything. That sounds obvious. In practice it required seeing clearly enough what was and wasn't working to justify stopping, and the model gave us that clarity for the first time. We concentrated effort on three specific levers — acupuncture repricing, visit-one-to-visit-two retention, and identifying and re-engaging our highest-value patients — because the model told us those three things accounted for the overwhelming majority of the revenue opportunity available to us without adding a single new patient.

In the medium term, decisions about providers, services, and capacity had a foundation they hadn't had before. Adding a provider or a service became a question the model could actually inform rather than a gut call dressed up as strategy.

Looking further out, we had a capacity ceiling number and a clear picture of what reaching the next revenue level required — which turned out to be structurally different from what we had assumed. The ceiling wasn't where we thought it was, and the path to it ran through retention, not acquisition.

The shift in how it felt to run the business was real. Before the model, uncertainty was ambient — we were making decisions without knowing what we didn't know. After it, the uncertainty was more specific. New questions surfaced as old ones were answered. But operating with specific, well-formed questions is a fundamentally different position than operating in the fog.

What this means for founders experimenting with AI now

Most clinic founders who are starting to use AI with their business data are somewhere in the early iteration phase — getting outputs that look impressive, not always knowing what to do with them. That experience is normal and it's not a sign that the technology isn't useful. It's a sign that the foundation the technology needs to run on hasn't been built yet.

The foundation is the model — the structured set of questions, validated assumptions, and interpretive framework that tells the AI what to look for and gives a human the context to know what the findings actually mean. Without it, AI produces confident-looking analysis that may or may not be answering the right questions. With it, the technology genuinely compounds over time.

Building that foundation is a different way of doing business. It requires a different relationship with your data, a willingness to do work that doesn't produce immediate visible results, and enough operational self-knowledge to validate what the analysis is telling you against what you actually know to be true about your clinic.

The question worth sitting with: if you already knew which three numbers actually determined whether your clinic was healthy, what would you ask the AI about your business?

Most founders don't have an answer yet. Getting there is the work.

About the author

Luke Bujarski

Luke Bujarski is the founder of LUFT, a strategic consulting practice for independent health clinics.

Menu Creep, and What We Did About It

By Luke Bujarski  ·  April 2026  ·  4 min read

It rarely happens all at once. A device rep comes in with a compelling ROI story and a limited-time offer. A nearby competitor starts promoting a new treatment and patients start asking about it. A slow quarter creates pressure to open a new revenue line. Someone on staff gets certified in something adjacent. Each decision, made individually, seems reasonable. Nobody sits down and decides to build a 24-service menu. It accumulates.

That is exactly what happened at Chrystal Clinic. Over several years of operating, our service list grew well past what the team could deliver with consistent quality and well past what any patient could easily navigate. And somewhere in the middle of that expansion, the economics of the clinic got harder to read. We didn't have a name for what was happening. We just knew the schedule was full and the margin picture kept being harder to explain.

What the menu was hiding

When we built the economic model and ran the service analysis, the picture that came back was clarifying in the way that uncomfortable findings tend to be. A new service creates a new line in a revenue report. That line is visible, trackable, and easy to point to in a team meeting. What doesn't appear in that same report is the margin picture underneath it: whether the service is profitable at the provider hour level, whether it is pulling time away from higher-margin work, and whether the patients it attracts are actually staying.

Total revenue by service is what we had been tracking. It told us what was popular. Revenue per provider hour by service told us what was profitable. Those two lists were not the same, and we had only ever looked at the first one.

A handful of services were carrying the economics of the whole menu. The rest were being quietly subsidized by the work that actually performed. The subsidy was invisible in our aggregate revenue figures. It only became visible when we separated out what each service produced per hour of provider time committed to delivering it.

The capacity problem we hadn't named

Adding a service does not add hours. It redistributes the hours that already exist. Provider time is the fixed resource in any clinic, and every service on the menu competes for a share of it.

What had happened at Chrystal Clinic was that lower-margin services were filling available slots because they were easier to book, faster to deliver, or more actively promoted. The schedule looked full. Utilization looked strong. But the revenue per hour being generated across that full schedule had quietly declined because the mix had shifted toward work that produced less per unit of provider time.

A clinic can be genuinely busy and genuinely under-earning at the same time. We lived that for longer than I'd like to admit before the model gave us language for it.

New services hadn't fixed retention either

There had been an assumption embedded in our expansion logic: that new services would bring in patients who stayed. Sometimes that was true. More often, a trending service attracted patients whose primary interest was that specific treatment, and whose likelihood of becoming a loyal, multi-visit patient was lower than the patients our core services were already retaining.

The visit-one-to-visit-two conversion problem in our core business didn't improve because we added something new to the menu. In some cases it got harder to see, because new services were generating first visits that made acquisition numbers look healthy while the underlying retention rate stayed flat.

Retention is an economic problem, not a menu problem. Adding services is a supply-side move. Retention lives in the behavior of the patients already in the system, and no new service line touches that directly.

What we actually did

Once the service economics were visible, the data made a clear case for simplification. The bottom thirty percent of our service variations, measured by revenue per provider hour, were not carrying their weight. Some were running at margins that made them actively dilutive to the overall economics. The analysis was not ambiguous.

Acting on it was harder than reading it. Some of those services had champions on staff who had built their practice around them. There were patients with strong preferences. Equipment had been purchased with the expectation of utilization. The switching costs were real, and the conversations required to make the changes were not comfortable ones.

We cut roughly thirty percent of our service variations anyway. The result was both operational and economic. Provider hours that had been scattered across a long menu concentrated toward the services that were actually performing. The patient conversation simplified. Booking became more straightforward. And the margin picture, which had been getting harder to explain for years, started making sense again.

The simplification felt like a contraction from the inside. From the outside, and in the numbers, it was a growth move.

The question to take back to your data

If you removed the three lowest-performing services on your menu by revenue per provider hour, what would that free up, and where would those hours go?

Most founders can't answer that from their current reporting. The number doesn't exist in any dashboard they're looking at. That gap, between what the reports show and what the economics actually are, is usually where the real growth conversation starts.

About the author

Luke Bujarski

Luke Bujarski is the founder of LUFT, a strategic consulting practice for independent health clinics.

Thinking in Arcs

By Luke Bujarski  ·  March 2026  ·  7 min read

For most of the time we ran Chrystal Clinic, we thought about patients one appointment at a time. That's not a criticism. It's just how the operating reality of a clinic is structured. The schedule is organized by appointment. Revenue gets reported by appointment. The booking system treats every visit as a discrete transaction. The patient who came in eight times last year and the patient who came in once look identical in the daily view of the schedule.

Our economic model changed that completely. When we built the patient lifecycle analysis and separated patients by where they were in their relationship with the clinic, we stopped seeing appointments and started seeing arcs. That reframe, from transaction to trajectory, turned out to be the most operationally consequential thing we did.

What an arc actually is

A treatment arc is the natural lifecycle of a patient's care. At Chrystal Clinic, three arc types emerged clearly from the data. Acute patients have a specific injury or problem with a defined endpoint, typically four to eight sessions with a clear resolution goal. Chronic patients have a systemic or long-standing condition requiring sustained treatment over months, with a tapering cadence as stability builds. Maintenance patients are people who had either resolved something or were well and wanted to stay that way, coming in monthly as a preventive practice.

None of this was invented. It was already true about our patient population. What the model did was make it visible and quantifiable. Once we could see which arc each patient was on, we could see where in that arc they were, what the natural drop-off risk looked like at each stage, and what their lifetime value was if they completed the arc versus dropped out at session two.

What changed operationally

The first thing that changed was retention visibility. We could now see which patients were approaching the natural drop-off point in their arc and hadn't rebooked. That's a different kind of alert than "this patient hasn't visited in 60 days." A patient three sessions into an acute arc who goes quiet is a different situation from a maintenance patient who skipped a month. The arc model gave us the context to tell the difference and respond accordingly.

The second thing that changed was how we identified our most valuable patients. MVPs at Chrystal Clinic weren't the patients who visited most frequently in absolute terms. They were the patients who had completed a full arc and converted to maintenance. That transition from acute or chronic treatment into an ongoing preventive relationship was the single most economically significant event in a patient's lifecycle with us. Getting a patient through her first arc wasn't just good clinical practice. It was the foundation of everything that came after.

The lifetime value gap between a patient who completed an arc and one who dropped out after two visits was not marginal. It was the difference that drove the $42,927 in year-one incremental revenue the economic model identified. The constraint was never acquisition. It was arc completion.

What it did for patient communication

Once we understood arc structure internally, we started communicating it externally. A patient who arrives understanding which arc she is on comes in with calibrated expectations. She knows roughly how many sessions to expect, what progress looks like at each stage, and what the natural endpoint is. That context changes her relationship to the early part of treatment, where most drop-off happens. She's not abandoning care when she feels slightly better after session two. She understands she's at session two of eight, not two of two.

We turned that into a sprint. The Find My Arc tool on the Chrystal Clinic website is the patient-facing output of the arc model: four questions, 60 seconds, a treatment arc with specific session counts, frequency guidance, and condition context delivered before the first appointment. It was built as a direct response to what the data showed about early drop-off. Patients were leaving not because the treatment wasn't working, but because they had no framework for understanding what working looked like over time.

This is what LUFT means by sprints. The diagnostic identifies the constraint. The sprint addresses it with a specific, bounded deliverable. Find My Arc is a retention sprint in patient education form. The analysis said visit-one-to-visit-two conversion was the largest revenue leak. The sprint built the tool that gives patients a reason to come back for visit two.

The question most clinics can't answer

Most clinic founders know their best patients by feel. They're the ones the front desk recognizes, the ones who rebook without prompting, the ones who refer friends. What most founders don't know is the economic weight of that cohort relative to everyone else: what share of total revenue they represent, what the path into that cohort looked like, and how many patients were one completed arc away from joining it and dropped out before they got there.

At Chrystal Clinic, patients who reached six or more visits generated 45.8% of all revenue and were worth 8.7 times more in lifetime value than patients who visited once. That cohort didn't happen by accident. They were patients who completed an arc, experienced a result, and built a relationship with the clinic that outlasted the original reason they came in.

The arc model made that visible. The sprint turned it into something the next patient could understand before she booked her first appointment.

You can try the Find My Arc tool at chrystalclinic.com/arc.

About the author

Luke Bujarski

Luke Bujarski is the founder of LUFT, a strategic consulting practice for independent health clinics.

The List Didn't Save Us

By Luke Bujarski  ·  April 2026  ·  3 min read

When I co-founded Chrystal Clinic in Sycamore, Illinois, we ran it the way most clinic founders run theirs. We worked hard, we tried things, and we kept a running list of initiatives to push growth forward. New marketing channels. Seasonal promotions. Content. Outreach campaigns. Every week there was something new to test, some new lever to pull.

The anxiety of that period is something I remember clearly. Not because the work was bad — it wasn't. It was because we were never sure which of it was actually working. We were spending real money and real hours across channels and campaigns without a clear picture of what was moving the needle and what was noise. You keep going because stopping feels like giving up, but the uncertainty is its own kind of exhaustion.

There is an entire industry built around that anxiety. It sells you activity. More things to do, more channels to test, more campaigns to run. The implicit promise is that if you just do enough of the right things, growth follows. I've seen frameworks that list 99 specific revenue-generating activities for cash-pay clinics — things to do during downtime, organized by role. Some of it is genuinely useful. Most of it is fuel for the same fire we were already burning.

What the data actually showed us

What changed things for us wasn't a new campaign. It was sitting down with five years of appointment-level data from our practice management system and building an economic model of the clinic from the ground up. Not a dashboard. Not a sales report. A model that traced every patient through their full lifecycle with us — how they came in, how many times they returned, where they stopped, and what that pattern cost us in lifetime revenue.

The embarrassing part, in retrospect, is how long it took us to do it. The data had been sitting there the whole time.

What we found was that 49% of new patients never returned after their first visit. Nearly half. We had been spending time and money driving new people through the door while losing half of them before they came back a second time. The model quantified exactly what that leak was costing us in lost lifetime revenue — and then identified the specific point in the care arc where it was happening.

The list of initiatives we had been working through didn't touch that problem at all. Not because they were bad ideas — some of them were fine. But they were aimed at acquisition when the real constraint was downstream. We didn't have a new patient problem. We had a visit-one-to-visit-two problem, and we had never measured it.

The model reduced our task list to three things. Three specific, high-leverage moves that the data said were actually worth doing. Everything else we stopped, not because we gave up, but because we finally had a basis for prioritization that wasn't gut feel.

Why AI makes this more urgent, not less

A lot of clinic founders are now turning to AI to help manage growth — and I think that's right. AI is genuinely capable of handling the activity layer: scheduling outreach, drafting content, sequencing follow-ups, identifying patients who haven't returned. The 99-item checklist approach is exactly what AI can do efficiently and at scale.

But here is the thing we learned the hard way: AI accelerates whatever direction your economics are already pointing. If your retention funnel leaks at visit two, AI-powered outreach contacts the wrong patients faster. If your pricing is compressing margin on your most time-intensive service, optimized promotions discount it more efficiently. If your revenue is dangerously concentrated in one provider, no AI tool surfaces that risk — because it isn't looking at your economics, it's executing your activity list.

The economic model is what tells the AI which direction to point. Without it, you're automating effort that may be solving the wrong problem.

I'm not arguing against using AI. We use it now, and it's valuable. What I'm arguing is that the foundation has to come first. You need to know which constraints are actually limiting your revenue before you automate anything. That is a judgment call that requires seeing your specific data, understanding the economics of your specific patient lifecycle, and knowing which questions are worth asking. A language model working from your booking export doesn't bring that. Neither does a checklist.

The question worth asking

Most clinic founders I talk to are tracking revenue. Many are tracking new patients, average transaction value, maybe utilization. Those are the right metrics at the wrong resolution. They tell you what is happening at the surface. They don't tell you where the economic leak actually is, what it's costing you in lifetime revenue, or which of the ten things on your list is the one worth doing.

We built LUFT because the model we built for our clinic — the one that found $42,927 in year-one incremental revenue at zero additional cost — turned out to be the most useful thing we ever did for the business. More useful than any campaign we ran.

About the author

Luke Bujarski

Luke Bujarski is the founder of LUFT, a strategic consulting practice for independent health clinics.